Literature DB >> 18160199

Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets.

John W Wright1, Brent J Yamamoto, Joseph W Harding.   

Abstract

The renin-angiotensin system (RAS) mediates several classic physiologies including body water and electrolyte homeostasis, blood pressure, cyclicity of reproductive hormones and sexual behaviors, and the regulation of pituitary gland hormones. These functions appear to be mediated by the angiotensin II (AngII)/AT(1) receptor subtype system. More recently, the angiotensin IV (AngIV)/AT(4) receptor subtype system has been implicated in cognitive processing, cerebroprotection, local blood flow, stress, anxiety and depression. There is accumulating evidence to suggest an inhibitory influence by AngII acting at the AT(1) subtype, and a facilitory role by AngIV acting at the AT(4) subtype, on neuronal firing rate, long-term potentiation, associative and spatial learning, and memory. This review initially describes the biochemical pathways that permit synthesis and degradation of active angiotensin peptides and three receptor subtypes (AT(1), AT(2) and AT(4)) thus far characterized. There is vigorous debate concerning the identity of the most recently discovered receptor subtype, AT(4). Descriptions of classic and novel physiologies and behaviors controlled by the RAS are presented. This review concludes with a consideration of the emerging therapeutic applications suggested by these newly discovered functions of the RAS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160199      PMCID: PMC2276843          DOI: 10.1016/j.pneurobio.2007.10.009

Source DB:  PubMed          Journal:  Prog Neurobiol        ISSN: 0301-0082            Impact factor:   11.685


  322 in total

Review 1.  Angiotensin-(1-7): an active member of the renin-angiotensin system.

Authors:  I Kucharewicz; R Pawlak; T Matys; E Chabielska; W Buczko
Journal:  J Physiol Pharmacol       Date:  2002-12       Impact factor: 3.011

2.  Mn2(+)-activated aspartate aminopeptidase activity, subcellular localization in young and adult rat brain.

Authors:  M Ramírez; G Arechaga; S Garcia; B Sanchez; P Lardelli; J M de Gandarias
Journal:  Brain Res       Date:  1990-07-02       Impact factor: 3.252

3.  Comparative effects of angiotensin-(1-7) and angiotensin II on piglet pial arterioles.

Authors:  W Meng; D W Busija
Journal:  Stroke       Date:  1993-12       Impact factor: 7.914

4.  A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat.

Authors:  T A Hamilton; R K Handa; J W Harding; J W Wright
Journal:  Peptides       Date:  2001-06       Impact factor: 3.750

5.  The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus.

Authors:  D P Thewke; N W Seeds
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

6.  Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.

Authors:  Joohyung Lee; Tomris Mustafa; Sharon G McDowall; Frederick A O Mendelsohn; Michelle Brennan; Rebecca A Lew; Anthony L Albiston; Siew Yeen Chai
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

Review 7.  Stress and angiotensin II: novel therapeutic opportunities.

Authors:  Ines Armando; Alicia Seltzer; Claudia Bregonzio; Juan M Saavedra
Journal:  Curr Drug Targets CNS Neurol Disord       Date:  2003-12

8.  Quantification of hemorphins in Alzheimer's disease brains.

Authors:  Anne Poljak; Catriona A McLean; Perminder Sachdev; Henry Brodaty; George A Smythe
Journal:  J Neurosci Res       Date:  2004-03-01       Impact factor: 4.164

9.  Nonuniformity of CBF response to NE- or ANG II-induced hypertension in rabbits.

Authors:  A M Reynier-Rebuffel; P Aubineau; O Issertial; J Seylaz
Journal:  Am J Physiol       Date:  1987-07

Review 10.  Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.

Authors:  Wen G Jiang; Tracey A Martin; Christian Parr; Gaynor Davies; Kunio Matsumoto; Toshikazu Nakamura
Journal:  Crit Rev Oncol Hematol       Date:  2005-01       Impact factor: 6.312

View more
  25 in total

Review 1.  The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases.

Authors:  John W Wright; Joseph W Harding
Journal:  Pflugers Arch       Date:  2012-04-26       Impact factor: 3.657

Review 2.  International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].

Authors:  Sadashiva S Karnik; Hamiyet Unal; Jacqueline R Kemp; Kalyan C Tirupula; Satoru Eguchi; Patrick M L Vanderheyden; Walter G Thomas
Journal:  Pharmacol Rev       Date:  2015-10       Impact factor: 25.468

3.  The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance.

Authors:  Justin L Grobe; Connie L Grobe; Terry G Beltz; Scott G Westphal; Donald A Morgan; Di Xu; Willem J de Lange; Huiping Li; Koji Sakai; Daniel R Thedens; Lisa A Cassis; Kamal Rahmouni; Allyn L Mark; Alan Kim Johnson; Curt D Sigmund
Journal:  Cell Metab       Date:  2010-11-03       Impact factor: 27.287

4.  Telmisartan protects central neurons against nutrient deprivation-induced apoptosis in vitro through activation of PPARγ and the Akt/GSK-3β pathway.

Authors:  Tao Pang; Li-Xin Sun; Tao Wang; Zhen-Zhou Jiang; Hong Liao; Lu-Yong Zhang
Journal:  Acta Pharmacol Sin       Date:  2014-05-05       Impact factor: 6.150

5.  Long-Term Treatment with Losartan Attenuates Seizure Activity and Neuronal Damage Without Affecting Behavioral Changes in a Model of Co-morbid Hypertension and Epilepsy.

Authors:  Jana D Tchekalarova; Natasha Ivanova; Dimitrina Atanasova; Daniela M Pechlivanova; Nikolai Lazarov; Lidia Kortenska; Rumiana Mitreva; Valentin Lozanov; Alexander Stoynev
Journal:  Cell Mol Neurobiol       Date:  2015-10-13       Impact factor: 5.046

Review 6.  The Potential Therapeutic Capacity of Inhibiting the Brain Renin-Angiotensin System in the Treatment of Co-Morbid Conditions in Epilepsy.

Authors:  Natasha Ivanova; Jana Tchekalarova
Journal:  CNS Drugs       Date:  2019-11       Impact factor: 5.749

7.  Preliminary biochemical characterization of the novel, non-AT1, non-AT2 angiotensin binding site from the rat brain.

Authors:  Vardan T Karamyan; Jason Arsenault; Emanuel Escher; Robert C Speth
Journal:  Endocrine       Date:  2010-04-13       Impact factor: 3.633

8.  The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor.

Authors:  B J Yamamoto; P D Elias; J A Masino; B D Hudson; A T McCoy; Z J Anderson; M D Varnum; M F Sardinia; J W Wright; J W Harding
Journal:  J Pharmacol Exp Ther       Date:  2010-01-19       Impact factor: 4.030

9.  Characterization of a local renin-angiotensin system in rat gingival tissue.

Authors:  C F Santos; A E Akashi; T J Dionísio; C R Sipert; D N Didier; A S Greene; S H P Oliveira; H J V Pereira; C Becari; E B Oliveira; M C O Salgado
Journal:  J Periodontol       Date:  2009-01       Impact factor: 6.993

10.  Strain-dependent effects of sub-chronically infused losartan against kainic acid-induced seizures, oxidative stress, and heat shock protein 72 expression.

Authors:  Jane Tchekalarova; Natasha Ivanova; Daniela Pechlivanova; Kalina Ilieva; Milena Atanasova
Journal:  Cell Mol Neurobiol       Date:  2013-10-22       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.